Cardlytics Stock Beta
| CDLX Stock | USD 11.94 0.24 1.97% |
Cardlytics fundamentals help investors to digest information that contributes to Cardlytics' financial success or failures. It also enables traders to predict the movement of Cardlytics Stock. The fundamental analysis module provides a way to measure Cardlytics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cardlytics stock.
Cardlytics | Beta |
Cardlytics Company Beta Analysis
Cardlytics' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Cardlytics Beta | 1.47 |
Most of Cardlytics' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cardlytics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cardlytics Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Cardlytics is extremely important. It helps to project a fair market value of Cardlytics Stock properly, considering its historical fundamentals such as Beta. Since Cardlytics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cardlytics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cardlytics' interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Cardlytics has a Beta of 1.466. This is 14.53% higher than that of the Media sector and significantly higher than that of the Communication Services industry. The beta for all United States stocks is notably lower than that of the firm.
Cardlytics Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardlytics' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardlytics could also be used in its relative valuation, which is a method of valuing Cardlytics by comparing valuation metrics of similar companies.Cardlytics is currently under evaluation in beta category among related companies.
Cardlytics Institutional Holders
Institutional Holdings refers to the ownership stake in Cardlytics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Cardlytics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cardlytics' value.| Shares | D. E. Shaw & Co Lp | 2023-09-30 | 702.9 K | Marshall Wace Asset Management Ltd | 2023-12-31 | 623.4 K | Goldman Sachs Group Inc | 2023-12-31 | 593.4 K | Davidson Kempner Capital Management Lp | 2023-12-31 | 550 K | Nuveen Asset Management, Llc | 2023-12-31 | 520.7 K | General Equity Holdings Lp | 2023-09-30 | 476.2 K | Lpl Financial Corp | 2023-12-31 | 453.4 K | Landscape Capital Management,llc | 2023-12-31 | 350 K | Northern Trust Corp | 2023-12-31 | 320.2 K | Blackrock Inc | 2023-12-31 | 2.9 M | Vanguard Group Inc | 2023-12-31 | 2.2 M |
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cardlytics will likely underperform.
Cardlytics Fundamentals
| Return On Equity | -0.78 | ||||
| Return On Asset | -0.0629 | ||||
| Profit Margin | (0.44) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 700.94 M | ||||
| Shares Outstanding | 48.17 M | ||||
| Shares Owned By Insiders | 3.30 % | ||||
| Shares Owned By Institutions | 63.75 % | ||||
| Number Of Shares Shorted | 5.95 M | ||||
| Price To Earning | (3.47) X | ||||
| Price To Book | 4.44 X | ||||
| Price To Sales | 1.94 X | ||||
| Revenue | 309.2 M | ||||
| Gross Profit | 115.42 M | ||||
| EBITDA | (34.15 M) | ||||
| Net Income | (134.7 M) | ||||
| Cash And Equivalents | 157.04 M | ||||
| Cash Per Share | 4.77 X | ||||
| Total Debt | 266.11 M | ||||
| Debt To Equity | 0.42 % | ||||
| Current Ratio | 0.90 X | ||||
| Book Value Per Share | 3.39 X | ||||
| Cash Flow From Operations | (185 K) | ||||
| Short Ratio | 1.88 X | ||||
| Earnings Per Share | (3.69) X | ||||
| Price To Earnings To Growth | (0.24) X | ||||
| Target Price | 17.67 | ||||
| Number Of Employees | 434 | ||||
| Beta | 1.47 | ||||
| Market Capitalization | 575.2 M | ||||
| Total Asset | 574.14 M | ||||
| Retained Earnings | (1.11 B) | ||||
| Working Capital | 52.78 M | ||||
| Current Asset | 81.93 M | ||||
| Current Liabilities | 52.77 M | ||||
| Net Asset | 574.14 M |
About Cardlytics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cardlytics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardlytics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardlytics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Cardlytics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardlytics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardlytics will appreciate offsetting losses from the drop in the long position's value.Moving together with Cardlytics Stock
| 0.67 | SE | Sea Financial Report 21st of May 2024 | PairCorr |
Moving against Cardlytics Stock
| 0.83 | UONEK | Urban One Class Report 4th of July 2024 | PairCorr |
| 0.81 | LPTV | Loop Media Financial Report 9th of May 2024 | PairCorr |
| 0.78 | EVC | Entravision Communications Financial Report 2nd of May 2024 | PairCorr |
| 0.77 | WMG | Warner Music Group Financial Report 14th of May 2024 | PairCorr |
| 0.74 | IAS | Integral Ad Science Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to Cardlytics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardlytics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardlytics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardlytics to buy it.
The correlation of Cardlytics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardlytics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardlytics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardlytics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Cardlytics Piotroski F Score and Cardlytics Altman Z Score analysis. For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Cardlytics Stock analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Cardlytics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardlytics. If investors know Cardlytics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardlytics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.57) | Earnings Share (3.69) | Revenue Per Share 8.474 | Quarterly Revenue Growth 0.081 | Return On Assets (0.06) |
The market value of Cardlytics is measured differently than its book value, which is the value of Cardlytics that is recorded on the company's balance sheet. Investors also form their own opinion of Cardlytics' value that differs from its market value or its book value, called intrinsic value, which is Cardlytics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardlytics' market value can be influenced by many factors that don't directly affect Cardlytics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardlytics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardlytics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardlytics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.